Gut hormones may control blood flow to bones, new study hints
NCT ID NCT07679516
First seen Jul 01, 2026 · Last updated Jul 10, 2026 · Updated 3 times
Summary
This study investigates whether natural gut hormones—GIP, GLP-2, and amylin—can change how much blood flows to the bones. Fifteen healthy adults aged 25 to 50 will receive infusions of each hormone separately, and a placebo, while researchers measure bone blood flow using advanced imaging. The goal is to understand basic bone physiology, which could eventually inform treatments for bone conditions like osteoporosis.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- GIP, GLP-2, and amylin (as infusions)
- What this could lead to
- If these hormones are found to regulate bone blood flow, it could point toward new ways to treat or prevent bone diseases like osteoporosis.
- What could go wrong
- This is a very small, early study in healthy people, so results may not apply to those with bone conditions. It only measures short-term effects, not long-term outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMYLIN are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Rigshospitalet
Copenhagen, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new pill ACC017 be safely dosed? a trial seeks answers
- Can a fingerprint scan replace traditional drug tests?
- Gut feeling: could probiotics soothe the mind?
- A window to the brain? eye signals may track dopamine
- Can a common heartburn pill change how a cancer drug works?
- Breathing exercises may rewire tongue control — a pilot study puts the idea to the test